What is the level of liabilities of Saniona this year?
Saniona has a debt balance of 86.08 M SEK this year.
Saniona Liabilities 2024
Saniona Liabilities
86.08 M SEK
Ticker
SANION.ST
ISIN
SE0005794617
WKN
A110VV
In 2024, Saniona's total liabilities amounted to 86.08 M SEK, a -14.76% difference from the 100.99 M SEK total liabilities in the previous year.
Saniona Aktienanalyse
What does Saniona do?
Saniona AB is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutics for rare diseases. The company was previously known as Saniona AB (until 2014) and NeuroNova AB (until 2012). It was founded in Copenhagen, Denmark, in 2006 and quickly expanded to other countries. In 2013, the company opened an office in Boston, USA, to expand its activities in North America. Saniona AB is listed on the NASDAQ Stockholm and currently has over 60 employees worldwide. The company's business model revolves around discovering and developing drugs for rare diseases that have little to no existing therapies. They use a proprietary technology platform called Ion Channels and G Protein-Coupled Receptors (GPCRs) to identify novel compounds that could meet these urgent medical needs. Saniona AB aims to develop successful medications and sell them either through partnerships or their own marketing activities. The company operates in various areas, including rare diseases, the nervous system (developing drugs for movement disorders and psychiatric disorders), and diabetes and obesity. Saniona AB has several drug candidates in its pipeline targeting different therapeutic applications, with some in various stages of clinical development. One of its key products is Tesomet, a candidate for the treatment of Prader-Willi syndrome and hypothalamic-pituitary hormone disorders, which is currently in Phase 3 of clinical development. Another important candidate is AN788, being investigated in Phase 2 clinical studies for the treatment of idiopathic pulmonary fibrosis. In conclusion, Saniona AB is an emerging biopharmaceutical company developing innovative drugs for rare diseases. With a specialization in researching rare diseases with significant medical needs and unmet treatment options, the company utilizes a proprietary technology platform to identify new compounds that aim to fulfill these medical needs. With multiple drug candidates in development and a strong partnership strategy, Saniona is well-positioned to maximize the potential of its innovative therapies and benefit patients in need. Saniona ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Saniona's Liabilities
Saniona's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Saniona's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Saniona's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Saniona's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Saniona’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Saniona stock
What were the liabilities of Saniona compared to the previous year?
The liabilities of Saniona have increased by -14.76% dropped compared to the previous year.
What are the consequences of high debt for investors of Saniona?
High liabilities can pose a risk for investors of Saniona, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Saniona?
Low liabilities mean that Saniona has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Saniona affect the company?
An increase in liabilities of Saniona can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Saniona affect the company?
A decrease in the liabilities of Saniona can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Saniona?
Some factors that can influence the liabilities of Saniona include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Saniona so important for investors?
The liabilities of Saniona are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Saniona take to modify the liabilities?
To change its liabilities, Saniona can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Saniona pay?
Over the past 12 months, Saniona paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Saniona is expected to pay a dividend of 0 SEK.
What is the dividend yield of Saniona?
The current dividend yield of Saniona is .
When does Saniona pay dividends?
Saniona pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Saniona?
Saniona paid dividends every year for the past 0 years.
What is the dividend of Saniona?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Saniona located?
Saniona is assigned to the 'Health' sector.
Wann musste ich die Aktien von Saniona kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Saniona from 7/26/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/26/2024.
When did Saniona pay the last dividend?
The last dividend was paid out on 7/26/2024.
What was the dividend of Saniona in the year 2023?
In the year 2023, Saniona distributed 0 SEK as dividends.
In which currency does Saniona pay out the dividend?
The dividends of Saniona are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Saniona
Our stock analysis for Saniona Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Saniona Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
